Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.8M Sell
68,500
-222,900
-76% -$26.1M 0.01% 854
2026
Q1
$35.1M Buy
291,400
+46,800
+19% +$5.4M 0.06% 314
2025
Q4
$25.7M Buy
244,600
+82,600
+51% +$7.75M 0.04% 413
2025
Q3
$13.6M Sell
162,000
-134,500
-45% -$11.1M 0.02% 662
2025
Q2
$23.5M Buy
296,500
+51,300
+21% +$4.08M 0.04% 448
2025
Q1
$22M Buy
245,200
+43,600
+22% +$4.07M 0.06% 405
2024
Q4
$20.1M Buy
201,600
+71,600
+55% +$7.38M 0.05% 427
2024
Q3
$14.8M Buy
130,000
+55,900
+75% +$6.64M 0.04% 569
2024
Q2
$9.17M Buy
74,100
+10,200
+16% +$1.31M 0.02% 739
2024
Q1
$8.43M Sell
63,900
-1,100
-2% -$136K 0.02% 776
2023
Q4
$7.09M Buy
+65,000
New +$6.75M 0.02% 812
2023
Q3
Sell
-3,000
Closed -$346K 2069
2023
Q2
$346K Buy
+3,000
New +$341K ﹤0.01% 1689
2023
Q1
Hold
0
2046

Other funds holding MRK

Man Group's MRK Position: Q2 2026 in Review

Man Group increased its Merck (MRK) stake by 25% in Q2 2026, buying an estimated $23.1M and bringing the position to 990,469 shares worth $127M. The position accounts for 0.2% of the portfolio, ranked #109.

Man Group first reported a position in MRK in Q1 2018 and has held it in 31 quarters since. The position peaked at $260M in Q1 2021. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Man Group held 990,469 shares of Merck worth $127M as of Q2 2026.
  • Man Group bought 197,302 Merck shares in Q2 2026, an estimated $23.1M.
  • Merck made up 0.2% of Man Group's portfolio in Q2 2026, its #109 holding.
  • Man Group first reported a position in Merck in Q1 2018 and has held it in 31 quarters since.
  • Man Group's Merck position peaked at $260M in Q1 2021.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.